Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Reliability and Validity of Patient Oriented Eczema Measure (POEM) Korean Version

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2016, v.37 no.4, pp.22-29





  • Downloaded
  • Viewed

Abstract

Objectives: We developed a Korean translation of this questionnaire by sequential forward-and-backward translation. The purpose of this study is to validate the Korean version of the POEM, the “POEM-K” by Korean patients with atopic dermatitis (AD). Methods: A single-center prospective study was conducted with 50 participants diagnosed with AD. The POEM was translated to Korean version by an expert panel. Scoring Atopic Dermatitis (SCORAD) and Short Form 36 Health Survey (SF-36) were used as external comparators. Results: Twenty men and thirty women between the ages of 18 and 63 participated in the study. The test-retest reliability of the total POEM-K was estimated using the intra-class correlation coefficient (ICC) that showed a strong agreement (ICC = 0.72). By using Pearson correlation coefficients, we compared the POEM-K to SCORAD and yielded a concurrent validity that showed a significant result. The responsiveness of the POEM-K was represented by the effect size (ES) of 1.41 and statistically significant (p = 0.004). Conclusions: The Korean version of the POEM is a reliable, valid, and responsive disease-specific questionnaire for assessing the symptoms and quality of life of Korean patients with AD.

keywords
Atopic dermatitis, Patient Oriented Eczema Measure, Quality of life, Reliability, Validity


Reference

1

1. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151-60.

2

2. Boguniewicz M, Leung DY. 10. Atopic dermatitis. The Journal of allergy and clinical immunology. 2006;117(2 Suppl Mini-Primer):S475-80.

3

3. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR, International Study of A, et al. Is eczema really on the increase worldwide?. The Journal of allergy and clinical immunology. 2008;121(4):947-54

4

4. Institute HI. Every year 1 million people were treated for severe itching due to "atopic dermatitis". 2014. Available at: URL:http://www.nhic.or.kr./cms/board/board/Board.jsp ?act=VIEW&communityKey=B0039&boardId=22846.

5

5. Absolon CM, Cottrell D, Eldridge SM, Glover MT. Psychological disturbance in atopic eczema:the extent of the problem in school-aged children. The British journal of dermatology. 1997;137(2):241-5.

6

6. Schmitt J, Langan S, Williams HC. European Dermato-Epidemiology N, What are the best outcome measurements for atopic eczema? A systematic review. The Journal of allergy and clinical immunology. 2007;120(6):1389-98.

7

7. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1980;59:44-7.

8

8. Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Archives of dermatology. 2004;140(12):1513-9.

9

9. Kocks JW, Tuinenga MG, Uil SM, van den Berg JW, Stahl E, van der Molen T. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7:62.

10

10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-10.

11

11. Huisman AN, Wu MZ, Uil SM, van den Berg JW. Reliability and validity of a Dutch version of the Leicester Cough Questionnaire. Cough. 2007;3:3.

12

12. Portney LG, Watkins MO. Foundations of clinical research applications to practice. Prentice Hall Inc. 2000:5660-567.

상단으로 이동

Journal of Korean Medicine